These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25022707)

  • 41. Mouse liver lysosomes contain enzymatically active processed forms of Hyal-1.
    Boonen M; Puissant E; Gilis F; Flamion B; Jadot M
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1155-60. PubMed ID: 24667601
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Triple Cross-Linked Hyaluronic Acid Based on Tri-Hyal Technique Has More Durable Effect on Dermal Renewal.
    Chen R; Yang W; Sun J; Liu Y; An Q; Zhang F; Bai Z; Luan Q
    Clin Cosmet Investig Dermatol; 2022; 15():691-701. PubMed ID: 35450398
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel hyaluronic acid dermal filler: dermal gel extra physical properties and clinical outcomes.
    Monheit GD; Baumann LS; Gold MH; Goldberg DJ; Goldman MP; Narins RS; Bachtell N; Garcia E; Kablik J; Gershkovich J; Burkholder D
    Dermatol Surg; 2010 Nov; 36 Suppl 3():1833-41. PubMed ID: 20969660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bioresponsive hyaluronic acid-capped mesoporous silica nanoparticles for targeted drug delivery.
    Chen Z; Li Z; Lin Y; Yin M; Ren J; Qu X
    Chemistry; 2013 Jan; 19(5):1778-83. PubMed ID: 23303570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of Percutaneous Superficial Temporal Arterial Hyaluronidase Injection for Hyaluronic Acid Filler-Induced Necrosis of Frontotemporal Skin and/or the Ipsilateral Scalp With Subsequent Alopecia.
    Zheng C; Fu Q; Zhou GW; Xu X; Tian XM; Lai LY; Wu Q; Ding HF; Yu BY; Chen ML
    Aesthet Surg J; 2023 Feb; 43(2):NP77-NP83. PubMed ID: 36268599
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rheological evaluation of the physical properties of hyaluronic acid dermal fillers.
    Stocks D; Sundaram H; Michaels J; Durrani MJ; Wortzman MS; Nelson DB
    J Drugs Dermatol; 2011 Sep; 10(9):974-80. PubMed ID: 22052265
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyaluronidase in the correction of hyaluronic acid-based fillers: a review and a recommendation for use.
    Rzany B; Becker-Wegerich P; Bachmann F; Erdmann R; Wollina U
    J Cosmet Dermatol; 2009 Dec; 8(4):317-23. PubMed ID: 19958438
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gel properties of hyaluronic acid dermal fillers.
    Edsman K; Nord LI; Ohrlund A; Lärkner H; Kenne AH
    Dermatol Surg; 2012 Jul; 38(7 Pt 2):1170-9. PubMed ID: 22759254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative Analysis of Hyaluronidase-Mediated Degradation Among Seven Hyaluronic Acid Fillers in Hairless Mice.
    Kwak SS; Yoon KH; Kwon JH; Kang WH; Rhee CH; Yang GH; Cruz DJM; Son WC
    Clin Cosmet Investig Dermatol; 2021; 14():241-248. PubMed ID: 33727845
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Domain motions of hyaluronan lyase underlying processive hyaluronan translocation.
    Joshi HV; Jedrzejas MJ; de Groot BL
    Proteins; 2009 Jul; 76(1):30-46. PubMed ID: 19089975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyaluronidase Availability in Emergency Rooms: A Statewide Analysis.
    Zaki DP; Roohani I; Firriolo JM; Sawyer SJ; Wong TR; Bascone CM; Saldana GM; Pu LLQ
    Facial Plast Surg Aesthet Med; 2023; 25(2):97-102. PubMed ID: 36749135
    [No Abstract]   [Full Text] [Related]  

  • 52. Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer.
    Paiva P; Van Damme MP; Tellbach M; Jones RL; Jobling T; Salamonsen LA
    Gynecol Oncol; 2005 Aug; 98(2):193-202. PubMed ID: 15936804
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The investigation of hyaluronic acid and hyaluronidase-1 levels as tumour marker in larynx cancer.
    İnan HC; Yener M; Buyru N; Çelebi A; Yilmaz M; Çomunoğlu N
    Clin Otolaryngol; 2019 Nov; 44(6):914-918. PubMed ID: 31207115
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The science and art of hyaluronic acid dermal filler use in esthetic applications.
    Gold M
    J Cosmet Dermatol; 2009 Dec; 8(4):301-7. PubMed ID: 19958435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy, safety, and patient satisfaction of a monophasic cohesive polydensified matrix versus a biphasic nonanimal stabilized hyaluronic acid filler after single injection in nasolabial folds.
    Buntrock H; Reuther T; Prager W; Kerscher M
    Dermatol Surg; 2013 Jul; 39(7):1097-105. PubMed ID: 23506356
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A complete range of hyaluronic acid filler with distinctive physical properties specifically designed for optimal tissue adaptations.
    Segura S; Anthonioz L; Fuchez F; Herbage B
    J Drugs Dermatol; 2012 Jan; 11(1 Suppl):s5-8. PubMed ID: 22497038
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A guide to temporal fossa augmentation with small gel particle hyaluronic acid dermal filler.
    Moradi A; Shirazi A; Perez V
    J Drugs Dermatol; 2011 Jun; 10(6):673-6. PubMed ID: 21637909
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Longevity of effects of hyaluronic acid plus lidocaine facial filler.
    Raspaldo H; De Boulle K; Levy PM
    J Cosmet Dermatol; 2010 Mar; 9(1):11-5. PubMed ID: 20367667
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Volumizing with a 20-mg/mL smooth, highly cohesive, viscous hyaluronic acid filler and its role in facial rejuvenation therapy.
    Carruthers J; Carruthers A; Tezel A; Kraemer J; Craik L
    Dermatol Surg; 2010 Nov; 36 Suppl 3():1886-92. PubMed ID: 20969666
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Durability, Behavior, and Tolerability of 5 Hyaluronidase Products.
    Casabona G; Marchese PB; Montes JR; Hornfeldt CS
    Dermatol Surg; 2018 Nov; 44 Suppl 1():S42-S50. PubMed ID: 29894436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.